Stock Price Quote

CAPLIN POINT LABORATORIES LTD.

NSE : CAPLIPOINTBSE : 524742ISIN CODE : INE475E01026Industry : Pharmaceuticals & DrugsHouse : Private
BSE507.2015.7 (+3.19 %)
PREV CLOSE ( ) 491.50
OPEN PRICE ( ) 510.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 49075
TODAY'S LOW / HIGH ( )502.05 520.40
52 WK LOW / HIGH ( )300.1 686
NSE507.5515.8 (+3.21 %)
PREV CLOSE( ) 491.75
OPEN PRICE ( ) 511.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 507.55 (8252)
VOLUME 1068631
TODAY'S LOW / HIGH( ) 502.00 520.00
52 WK LOW / HIGH ( )303 686
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1990
Management Info
C C Paarthipan - Chairman Sridhar Ganesan - Managing Director
Registered Office

Address 3rd Floor, “ashvich Towers”,No.3, Developed Plots Industrial Estate,Perungudi,
Chennai,
Tamil Nadu-600096

Phone

Email info@caplinpoint.net

Website www.caplinpoint.net

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
II Floor , Kences Towers,No 1 Ramakrishna Street,North Usman Road, T Nagar,Chennai
Listing : BSE, NSE, Chennai

NEWS

19Apr Announcement under Regulation 30 (LOD
Caplin Steriles Gets USFDA Approval for Milrinone lactate Injection
19Apr Caplin Point Laboratories zooms after
Caplin Point Laboratories is currently trading at Rs. 488.45, up by 22.2..
19Apr Caplin Point Laboratories’ arm gets US
Caplin Steriles (Caplin), a Subsidiary Company of Caplin Point Laborator..
19Apr Caplin Point Laboratories submits pres
Caplin Point Laboratories has informed that it enclosed a Press Release..
29Jan Board Meeting Intimation for Un-Audit
CAPLIN POINT LABORATORIES LTD.has informed BSE that the meeting of the B..

Financials

in Millions
QTR Dec 20 ANNUAL 20
Net Profit414.81976.39
Gross Profit 553.1 2531.25
Operating Profit 609.62729.64
Net Sales 1231.65278.25

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  3905.70 (8.77%)
M.Cap ( in Cr)9720.00
Neuland Laboratories (BSE)
peergroup  2674.85 (7.69%)
M.Cap ( in Cr)3505.51
Dr. Reddys Lab (BSE)
peergroup  5153.95 (3.69%)
M.Cap ( in Cr)85710.82
Abbott India (BSE)
peergroup  14860.60 (1.08%)
M.Cap ( in Cr)31543.63
Pfizer (BSE)
peergroup  5480.60 (2.86%)
M.Cap ( in Cr)25161.25

Shareholding Pattern

PROMOTERS 69.03%
NON-INSTITUTION 29.01%
FI/BANKS/INSURANCE 0.83%
MUTUAL FUNDS/UTI 0.45%
GOVERNMENT 0%
FII 0%

About Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd. was incorporated in the year 1990. Its today's share price is 507.2. Its current market capitalisation stands at Rs 3808.61 Cr. In the latest quarter, company has reported Gross Sales of Rs. 5278.25 Cr and Total Income of Rs.5937.97 Cr. The company's management includes Avaneesh Singh, D Sathyanarayanan, CK Gariyali, KC John, R Ravichandran, V Thirumalai, DP Mishra, Sridhar Ganesan, C C Paarthipan.

It is listed on the BSE with a BSE Code of 524742 , NSE with an NSE Symbol of CAPLIPOINT and ISIN of INE475E01026. It's Registered office is at 3rd Floor, “ashvich Towers”,No.3, Developed Plots Industrial Estate,PerungudiChennai-600096, Tamil Nadu. Their Registrars are ACC Ltd. It's auditors are CNGSN & Associates, CNGSN & Associates LLP, M Raghunath & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)